フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- Data Shows 0.4 log10 Difference Between the High-Dose and the Placebo Control Group ? -- Dose...
Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- Clears Clogged Arteries ? -- Raises HDL ? -- Reduces CK Enzyme Marker: Suggesting It...
Samaritan Pharmaceuticals (AMEX:LIV): ? -- Completed Phase II Stage 1 (10 Day Monotherapy) ? -- Expect to Report Stage I Preliminary Results...
The Samaritan Foundation and Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today on National DNA day, it...
Samaritan Pharmaceuticals Inc. (AMEX:LIV) ? -- David W. Munno, Merrill Lynch VP of biotechnology, stated, "Large-cap biotech firms need some...
Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, its shareholders are invited to the Annual...
Samaritan Pharmaceuticals, Inc. (AMEX:LIV) is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received...
Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- PII/III HIV Oral Entry Inhibitor Drug ? -- Cardiovascular Drug SP-1000 ? -- Alzheimer's Drug...
Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, it has new preclinical data gathered in a series of...
Samaritan Pharmaceuticals Inc. (AMEX:LIV): ? -- Alzheimer's Expected to Claim 14M Lives by 2050 ? -- Analyst Predict Alzheimer's Market Could...
Fourth graph, URL should read: http://www.samaritanpharma.com/images/havestemcellsarrived.pdf (sted http://www.chiefexecutive.net/ME2/dirmod.asp?...
Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today its Alzheimer's adult stem cell drug SP-sc04, which...
Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, it is starting a second Phase II monotherapy trial, of...
Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, announced today the welcoming of Dr. Pauline S. Nys, a distinguished...
Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has received its unique CAS Registry Number for the...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約